Company Lexington BioSciences Inc Canadian Securities Exchange
Equities
CA5290201097
Medical Equipment, Supplies & Distribution
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donald McInnes
CEO | Chief Executive Officer | 60 | 15/04/20 |
Bryan Disher
DFI | Director of Finance/CFO | 66 | 20/12/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Disher
DFI | Director of Finance/CFO | 66 | 20/12/16 |
Tamara Manuel
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 23,669,560 | 0 | 0 | 13.79 % |
Stock B | 1 | 3,786,840 | 3,785,340 ( 99.96 %) | 0 |
Company contact information
Lexington Biosciences, Inc.
1055 West Hastings Street Suite 1900
V6E 2E9, Vancouver
+
Sector
1st Jan change | Capi. | |
---|---|---|
-7.58% | 181B | |
-0.27% | 108B | |
-6.95% | 66.12B | |
+2.90% | 50.65B | |
+5.16% | 43.11B | |
+3.49% | 40.74B | |
+19.29% | 31.6B | |
+16.38% | 25.56B | |
-7.04% | 24.16B |